AnaptysBio, Inc. (ANAB)

58.74 -4.41 (-6.98%) USD  |  NASDAQ  |  May 18, 16:00
58.34 -0.40 (-0.68%) Pre-Market: 09:18
More

AnaptysBio EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Rocket Pharmaceuticals, Inc. --